Clinical Trial Update: A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial update for U-500 insulin (LY041001) in participants with Type 2 diabetes; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• U-500 insulin (LY041001) (insulin concentrate U-500 (LY041001))

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: TERMINATED | Results posted: 2023-10-18